Profil
Gabriel Festoc was the founder of GeneSystems SA, which was founded in 2000, where he held the titles of President & Chief Executive Officer from 2000 to 2009.
He also worked as Deputy Chief Executive Officer at Biosims Technologies SAS.
Dr. Festoc was Co-Chairman at Polyplus-transfection SA from 2009 to 2023.
Ehemalige bekannte Positionen von Gabriel Festoc
| Unternehmen | Position | Ende |
|---|---|---|
Polyplus-transfection SA
 Polyplus-transfection SA BiotechnologyHealth Technology Polyplus-transfection SA develops and sells solutions for the delivery of nucleic acids in research, bio production, and therapeutics. Its products are transfection reagents and trademarks, mainly for gene and cell therapies. The company was founded by Jean-Paul Behr, Anne-Lise Monjanel, Joelle Bloch, and Patrick Metz in January 2001 and is headquartered in Illkirch-Graffenstaden, France. | Vorstandsvorsitzender | - |
Biosims Technologies SAS
 Biosims Technologies SAS Miscellaneous Commercial ServicesCommercial Services Biosims Technologies SAS engages in research and development in life sciences. It accelerates drug discovery and biomarker projets with sensitive and multiplex immunoassay technologies. Biosims Technologies was founded by Guillaume Legent, Christine Heuclin and Clermont Ferrand in 2010 and is headquartered in Rouen, France. | Corporate Officer/Principal | - |
GeneSystems SA
 GeneSystems SA Pharmaceuticals: MajorHealth Technology GeneSystems SA develops and commercializes innovative identification and detection products for proteins. The company develops innovative proteomics products that allow drug companies and life scientists to obtain a digital snapshot of the protein-signaling pathways in disease samples. This snapshot allows drug therapies to be personalized for patients. GeneSystems was founded in 2000 and is headquartered in Bruz, France. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
GeneSystems SA
GeneSystems SA Pharmaceuticals: MajorHealth Technology GeneSystems SA develops and commercializes innovative identification and detection products for proteins. The company develops innovative proteomics products that allow drug companies and life scientists to obtain a digital snapshot of the protein-signaling pathways in disease samples. This snapshot allows drug therapies to be personalized for patients. GeneSystems was founded in 2000 and is headquartered in Bruz, France. | Health Technology |
Biosims Technologies SAS
Biosims Technologies SAS Miscellaneous Commercial ServicesCommercial Services Biosims Technologies SAS engages in research and development in life sciences. It accelerates drug discovery and biomarker projets with sensitive and multiplex immunoassay technologies. Biosims Technologies was founded by Guillaume Legent, Christine Heuclin and Clermont Ferrand in 2010 and is headquartered in Rouen, France. | Commercial Services |
Polyplus-transfection SA
Polyplus-transfection SA BiotechnologyHealth Technology Polyplus-transfection SA develops and sells solutions for the delivery of nucleic acids in research, bio production, and therapeutics. Its products are transfection reagents and trademarks, mainly for gene and cell therapies. The company was founded by Jean-Paul Behr, Anne-Lise Monjanel, Joelle Bloch, and Patrick Metz in January 2001 and is headquartered in Illkirch-Graffenstaden, France. | Health Technology |
